Skip to main content

Featured

Nerve Block Therapy Offers Hope for Migraine Sufferers

                           Calgary neurologist Dr. Serena Orr injecting a patient to help treat migraines.  Researchers in Calgary are spotlighting a promising treatment for people living with severe migraines: occipital nerve blocks . This approach involves injecting a small amount of anesthetic near the occipital nerves at the back of the head, which can interrupt pain signals and provide rapid relief. Neurologist Dr. Serena Orr of the University of Calgary has been at the forefront of this research, recommending updates to the American Headache Society’s guidelines for emergency departments. The new recommendations encourage doctors to consider nerve blocks as a frontline option for patients arriving with debilitating migraine attacks. Patients who have received the treatment report significant improvement. Some describe it as the first time they’ve been able to escape the crushing pain, nausea,...
Post a Comment
Read more

article

Labels

Wall Street Edges Up as Investors Await Inflation Report

Wall Street remained cautiously optimistic today as investors eagerly awaited the release of a crucial U.S. inflation report. Here’s a snapshot of today’s market activity:

  1. S&P 500 and Nasdaq: The S&P 500 held steady, with gains and losses evenly distributed among its constituent stocks. Meanwhile, the Nasdaq inched up, hovering just below its all-time high.

  2. Winners and Losers:

    • Walgreens Boosts Alliance: The pharmacy giant saw a staggering 24.7% drop in its stock price after reporting results that fell short of expectations and lowering its outlook. The possibility of hundreds of store closures in the next three years added to investor concerns.
    • Levi Strauss: The jeans maker’s stock plummeted 16.6% due to disappointing quarterly revenue results and a less-than-rosy earnings forecast for the year.
    • McCormick: On the flip side, spice maker McCormick surged 5.8%, outperforming analysts’ earnings forecasts.

  3. Inflation and Consumer Spending:

    • The U.S. economy expanded at a 1.4% annual pace from January through March, a slight revision from the previous estimate of 1.3%. This growth rate is the slowest since spring 2022.
    • Consumer spending, a key driver of economic growth, grew at a modest 1.5% rate, down from the initial estimate of 2%. Persistent inflation and high interest rates continue to squeeze consumers.
    • The Federal Reserve faces the delicate task of taming inflation without pushing the economy into a recession.

  4. What’s Next?

    • The eagerly anticipated personal consumption expenditures index (PCE), the Fed’s preferred measure of inflation, is due for release. Economists expect a modest easing of inflation to 2.6% in May, down from April’s 2.7% reading.
    • Nike, however, faced a different fate. The athletic wear company’s shares plummeted 15% after missing Wall Street’s revenue targets and revising its full-year sales guidance downward.

Investors remain cautiously optimistic, balancing economic data and corporate performance. All eyes are on the inflation report, which could shape the Federal Reserve’s next move on interest rates. Stay tuned for further developments! 

    Labels:

    Comments

    Post a Comment